FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

New Vitalis Pharmacy LLC dba New Vitalis Pharmacy Testosterone Cypionate Testosterone Recall

Testosterone Cypionate Testosterone Propionate, 180mg/mL, 20mg/mL, 1 mL vial, Rx only,…

New Vitalis Pharmacy LLC dba New Vitalis Pharmacy · Louisville, KY

Risk level
Class II
Reported by FDA
Oct 6, 2021
Recall ID
D-0899-2021
Check your lot numberHow we source this data

Summary

New Vitalis Pharmacy LLC dba New Vitalis Pharmacy recalled Testosterone Cypionate Testosterone starting Sep 22, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0899-2021 on Oct 6, 2021. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

Testosterone Cypionate Testosterone Propionate, 180mg/mL, 20mg/mL, 1 mL vial, Rx only, New Vitalis Pharmacy 4139 Cadillac Ct # 201 Louisville, KY 40213

Lot numbers, UPCs & expiration codes

Lot, expiry: Lot #AL07202021@901, Exp 9/18/21; Lot #AL07272021@901, Exp 9/25/21; Lot #AL08032021@901, Exp 10/2/21; Lot #AL08102021@901, Exp 10/9/21; Lot #AL08172021@901, Exp 10/16/21; Lot #AL08242021@901, Exp 10/23/21

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0899-2021
Classification
Class II
Status
Terminated
Recall initiated
Sep 22, 2021
FDA report date
Oct 6, 2021
Quantity
1,347 vials
Recall type
Voluntary: Firm initiated
Recalling firm
New Vitalis Pharmacy LLC dba New Vitalis Pharmacy

Original FDA data

Every field from FDA enforcement report D-0899-2021, exactly as published.

Show all FDA fields
City
Louisville
State
KY
Status
Terminated
Country
United States
Event ID
88733
Address
4139 Cadillac Ct Ste 201
Code information
Lot, expiry: Lot #AL07202021@901, Exp 9/18/21; Lot #AL07272021@901, Exp 9/25/21; Lot #AL08032021@901, Exp 10/2/21; Lot #AL08102021@901, Exp 10/9/21; Lot #AL08172021@901, Exp 10/16/21; Lot #AL08242021@901, Exp 10/23/21
Postal code
40213-1578
Report date
Oct 6, 2021
Product type
Drugs
Recall number
D-0899-2021
Classification
Class II
Recalling firm
New Vitalis Pharmacy LLC dba New Vitalis Pharmacy
Product quantity
1,347 vials
Termination date
May 12, 2024
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Testosterone Cypionate Testosterone Propionate, 180mg/mL, 20mg/mL, 1 mL vial, Rx only, New Vitalis Pharmacy 4139 Cadillac Ct # 201 Louisville, KY 40213
Distribution pattern
Nationwide within the United States
Recall initiation date
Sep 22, 2021
Initial firm notification
Letter
Center classification date
Sep 30, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0899-2021, published Oct 6, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls